Showing results (61-70 of 91) with videos related to
Sort By:
Pageof 10
Radiology|November 7, 2023
A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)Claudia I Henschke, Rowena Yip, Dorith Shaham, et al.The Annals of Thoracic Surgery|June 19, 2026
STS Expert Consensus Document (2026) on Addressing Definition and Practices of Sublobar Resection in Non-small Cell Lung CancerOnkar V Khullar, Biniam Kidane, Nasser Altorki, et al.Annals of Epidemiology|April 10, 2003
Lung cancer risk in white and black AmericansSteven D Stellman, Yu Chen, Joshua E Muscat, et al.Cancer Immunity|December 2, 2006
Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6)Hearn J Cho, Otavia L Caballero, Sacha Gnjatic, et al.Plos One|August 13, 2013
The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancerThomas John, Maud H W Starmans, Yao-Tseng Chen, et al.JAMA Oncology|August 1, 2024
Recurrence of Non-Small Cell Lung Cancer With Visceral Pleural Invasion: A Secondary Analysis of a Randomized Clinical TrialNasser Altorki, Xiaofei Wang, Bryce Damman, et al.Lancet (London, England)|September 23, 2021
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trialEnriqueta Felip, Nasser Altorki, Caicun Zhou, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2019
Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO GuidelineBryan J Schneider, Nofisat Ismaila, Joachim Aerts, et al.Journal for Immunotherapy of Cancer|October 30, 2023
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trialCaicun Zhou, Minu K Srivastava, Hao Xu, et al.The Journal of Surgical Research|July 18, 2024
Reporting Minority Race and Ethnicity in Cardiovascular and Thoracic JournalsShahenda Khedr, Julie Hong, Ninon Forter-Chee-A-Tow, et al.Pageof 10